myo-Inositol 1,4,6-u-&phosphate, in optically inactive and active forms, was prepared in order to compare its biological activity with that of myo-inositol 1,3,4,6-tetrakisphosphate which releases Ca2+ from an intracellular store.
Synthesis of 5-phosphonate analogues of myo-inositol 1,4,5-trisphosphate: possible intracellular calcium antagonists
โ Scribed by C.E. Dreef; W. Schiebler; G.A. van der Marel; J.H. van Boom
- Publisher
- Elsevier Science
- Year
- 1991
- Tongue
- French
- Weight
- 294 KB
- Volume
- 32
- Category
- Article
- ISSN
- 0040-4039
No coin nor oath required. For personal study only.
โฆ Synopsis
The racemlc 5phosphonate analogues IV and V of myuinosltol 1,4,5trrsphosphate were readily accessible by btsphosphorylatlon of the common precursor 6, removal of the pmethoxybenzyl group, phosphonylabon and subsequent hydrogenolysls of the benzyl protectmg groups The methylphosphonate analogue IV acted as a calcium antagonist In permeablllzed human platelets, whereas the (difluoromethyl)phosphonate V exhibited only very little antagonlstlc acttvlty
It IS generally accepted now that hydrolysis of phosphatldylmosltol [4,5]blsphosphate by receptor mediated actlvatlon of phosphollpase C results in the formation of myo-inositol 1,4,5-trrsphosphate
๐ SIMILAR VOLUMES
Novel routes to myo-inositol 1,4,5trisphosphate and a phosphorothioate analogue involving mixed P(V) and P(III) chemistry have been developed. Phosphorylation of 2,3,6-tri-O-benzyl-myo-inositol l-[di-(2,2,2-trichloroethyl) phosphate] with bis(2,2,2-trichloroethyl) phosphorochloridate gave a mixture